PHARMA LITERATI

One of the start-ups in Mumbai requires for B. Pharm/ M. Pharm students for a minor project for the period of one month . This is not a job opportunity, but a temporary opportunity with flexible timing.  The project is related to pharmaceutics/ drug delivery systems. Proper guidance would be provided to the students regarding the project.  This is a home based opportunity and requires internet connection. Profile: Internet searching; d ata collection, interpretation and analysis of the same. The candidate need to submit the assignment within stipulated time.  Remuneration: Based on number of hours in a month. Essential r equirement: Basic understanding of pharmaceutics. Third year/ final year B.Pharma students as well as M. Pharm students are eligible.  Job location: Since this is a home based opportunity, there is no restriction of the job location. However, Mumbai/ Pune or Nashik candidates are p...

Dear All, Every week of thousands of patent applications are published in India. The  patent applications filed by the pharma academic research institutes in India  go un-noticed. We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at pharmaliterati@gmail.com Indian patent applications published on 26 th  June 2015 Invention Application No Inventors Institute Colon targeted pharmaceutical composition of Esomeprazole magnesium trihydrate and curcumin 2508/MUM/2013 A 1) Mayur Dilipkumar Kapadia 2) Dr. Subhashkumar S. Vaghani Shree Dhanvantary Pharmacy College, Surat, Gujarat. Multiparticulate pharmaceutical composition of Etodolac and Curcumin 2509/MUM/2013 A...

Dear All, A recent study by Scopus database which is the world's largest abstract and citation database on scientific literature, India lags behind Kenya and Chile. The country has only four researchers for 10,000 working people while Kenya and Chile have six and seven, respectively, according to Scopus database which is the world's largest abstract and citation database on scientific literature. Analyzing this data, Nature magazine says Brazil, which has been growing scientifically, has 14 researchers per 10,000 working people, and China has 18. The UK and the US top the table with 79 researchers each followed by Russia with 58. Nature Magazine, in its May 2015 report, also said: "India's publications generate fewer citations on an average than those of other science-focused nations, including Brazil and China." It further states that relative to its size, India has very few scientists and many Indian-born researchers leave for positions abr...

Dear All, We are pleased to announce the collaboration with FICCI’s CCIPR, a first of its kind of course on IPR and Pharmaceutical R & D .   The course details can be accessed at http://ficcipharmacourse.ficciipcourse.in/ About Course Federation of Indian Chambers of Commerce and Industry (FICCI) is conducting an Online Certificate Course on IPR and Pharmaceutical R&D. Objective To provide the platform to understand the working of pharmaceutical industry, its business models, research, regulatory aspects and its relevance with respect to intellectual property rights. Importance of the Course Pharmaceutical industry is a research based industry and requires scientists in huge numbers every year. The growing pharmaceutical R&D operations fuel the need for understanding IPR (Intellectual property rights) for pharmacy graduates and those in research. IPR is important in this era of globalization and competition. The current academic syllabus of ph...

Dear All,  Under the KIRAN-IPR scheme initiated by Department of Science & Technology, Government of India for the women scientists, applications are invited by the Patent Facilitating Centre (PFC) of Technology Information, Forecasting and Assessment Council (TIFAC). According to the scheme women scientists would get trained in the area of Intellectual Property Rights (IPR) and their management for a period of one year. Interested and eligible candidates can apply for the same before, July 19, 2015 through online application. Pay scale: Rs. 20,000/- pm for MSc/ BTech/MBBS/ BPharma  Rs. 30,000/- pm for PhD/MTech/MVSc/ MPharma Eligibility: Educational qualification: Candidates having Master’s Degree in Science or Bachelor’s degree in Engineering/Technology from any recognized university can apply for the scheme.  Those who have experience of handing computerized database and have quality in subject areas like Chemistry, Drugs, Food & Pharma...

Dear All, The transformations taking place throughout all healthcare sectors will have repercussions for the pharmaceutical industry. How will they affect industry prospects, and what are the implications for drug manufacturers be affected? According to Matthew Hudes, US Managing Principal for Deloitte’s Biopharma practice , the pharmaceutical industry is poised to enter an “inflection point” in which it may produce more medicines that have a dramatic impact on disease than ever before. This is being spurred, Hudes said, by the industry’s need to replenish a tidal wave of patent expirations and by a new-found willingness to embrace “open innovation,” the practice of working with other organizations, even competitors, in obtaining the medical and scientific expertise needed to develop better therapies.  Deloitte recently issued a report showing that drugs sourced via open innovation are 3 times more likely to achieve late-phase clinical success versus those culti...

National Institution for Transforming Indian (NITI) has been constituted on 1st January, 2015. NITI Aayog seeks to engage 20 (Twenty) Young Professionals with an aptitude for Public Policy and Development under the Young Professionals programme. The Young Professionals Programme (YPP) seeks to provide a unique opportunity for persons below the age of 32 years of exposure to Public Policy and Development. It seeks to engage persons with a passion for development and the potential to become future leaders in their respective fields. Under this programme, highly qualified, motivated individuals will work in the NITI Aayog in areas that are relevant to development policy and provide high quality professional inputs in Economics, Finance, Education, Public Health, Social Sciences, Engineering, Urban Planning and Infrastructure amongst others. This highly selective programme requires candidates to demonstrate proven academic, credentials, professional achievement and...

Dear All, We had posted about bloggers joining our team. See  http://pharmaliterati.blogspot.in/2015/05/bloggers-required.html We are pleased to welcome our third blogger in the series, Mr. Kabin Maleku from the beautiful country of Nepal.    He has done her M. Pharma from BITS Pilani and B. Pharma from  NET pharmacy college, Raichur.    We welcome Kabin to our team and wish a luck in the endeavor.  To join as a blogger with Pharma Literati team, send your CV to  pharmaliterati@gmail.com Team Pharma Literati.

Dear All, The medical fraternity has been using CIMS since long. The database used for critical prescription information, medical news and articles is now available as mobile application.  The Free CIMS app delivers critical prescribing information, medical news and CME articles as well as clinical calculators essential to physicians’ daily practice needs. With CIMS available across multiple platforms and devices, you can now easily and conveniently find the most up-to-date and relevant drug information you need anytime, anywhere.

Kamil Hamied has quit Cipla, surprising those who had expected him to take a leadership role at India's third-largest drug company. A few months ago, Cipla founder YK Hamied had referred to nephew Kamil (33) and the latter's sister Samina Vaziralli (38) as family members who would carry on the family tradition. A Cipla spokesperson said the younger Hamied was leaving to pursue his own interests and sought to downplay the suggestion that there might have been disaffection on his part, making the point that he had backed the move to bring in professional managers to run the drug maker. Cipla has been going through a spell of turmoil of late, with several changes at the top. Hamied was chief strategy officer and managed European operations before Frank Peters was hired to take charge of the region. There has been talk about Hamied having an uncomfortable working relationship with Subhanu Saxena, who was appointed chief executive officer in 2012. To be sure, many family r...

Dear All, The Union Minister of Chemicals & Fertilizers, Ananth Kumar has released Task Force report on enabling the Private Sector to lead the growth of pharmaceutical sector .  Speaking at the release ceremony in New Delhi the Minister said that the Government wants to encourage a robust Pharmaceutical Industry in the country that is upgraded, standardized, innovative, globally competitive and can produce formulations at affordable costs. He said in this regard, setting up of the Task Force was one of the major initiative of the Government.The Task Force has given recommendations towards concerns and constraints facing the sector and suggested measures that would augment domestic production.  Ananth Kumar said that the Government is very keen on early implementation of the recommendations of the Task Force and it would come out with an action taken report on these recommendations in 100 days. Speaking on the occasion, Minister of State for Chemicals and Fert...